Prognostic value of bax, cytochrome c, and caspase-8 protein expression in primary osteosarcoma

Hybridoma

Volumn 26, Issue 6, 2007, Pages 355-362

  Kaseta, Maria Kyriaki A ^a,c   Gomatos, Ilias P ^a   Khaldi, Lubna ^b   Tzagarakis, George P ^a   Alevizos, Leonidas ^a   Themistocleous, George S ^a   Leandros, Emmanuel ^a   Soucacos, Panayiotis N ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^c NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CYTOCHROME C; PROTEIN BAX;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; BONE CANCER; BONE LESION; BONE TISSUE; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OSTEOSARCOMA; OVERALL SURVIVAL; PATHOLOGY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; SURVIVAL; SURVIVAL RATE; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGED; BCL-2-ASSOCIATED X PROTEIN; BONE NEOPLASMS; CASPASE 8; CYTOCHROMES C; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOSARCOMA; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 37549031248     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2007.0519     Document Type: Article

References (42)

1. Campanacci M: Classic osteosarcoma. In: Bone and Soft Tissue Tumors: Clinical Features, Imaging, Pathology and Treatment. Aulo-Gaggi (ed.). Springer Verlag, Wien, New York, 1990, pp. 455-505.
2. Duffaud F, Digue L, Baciuchka-Palmaro M, Volot F, Perles-Daniel C, Garbe L, and Favre R: Osteosarcomas of flat bones in adolescents and adults. Cancer 2000;88:324-332.
3. Bacci G, Picci P, Ferrari S, Sangiorgi L, Zanone A, and Brach del Prever A: Primary chemotherapy and delayed surgery for non-metastatic osteosarcoma of the extremities. Results in 28 patients. Eur J Cancer 1994;30:620-626.
4. Davis AM, Bell RS, and Goodwin PJ: Prognostic factors in osteosarcoma: a critical review. J Clin Oncol 1994;12:423-431.
5. Papagelopoulos PJ, Galanis EC, Vlastou C, Nikiforidis PA, Vlamis JA, Boscainos PJ, Fragiadakis EG, Stamos KG, Pantazopoulos T, and Sim FH: Current concepts in the evaluation and treatment of osteosarcoma. Orthopedics 2000;23:858-867.
6. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, and Korsmeyer SJ: Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001;292:727-730.
7. Desagher, S, and Martinou JC: Mitochondria as the central control point of apoptosis. Trends Cell Biol 2000;10:369-377.
8. Diaz GD, Li Q, and Dashwood RH: Caspase-8 and apoptosis-inducing factor mediate a cytochrome c-independent pathway of apoptosis in human colon cancer cells induced by the dietary phytochemical chlorophyllin. Cancer Res 2003;63:1254-1261.
9. Gu Q, Wang JD, Xia HH, Lin MC, He H, Zou B, Tu SP, Yang Y, Liu XG, Lam SK, Wong WM, Chan AO, Yuen MF, Kung HF, and Wong BC: Activation of the caspase-8/Bid and Bax pathways in aspirin-induced apoptosis in gastric cancer. Carcinogenesis 2005;26:541-546.
10. Liang H, Salinas RA, Leal BZ, Kosakowska-Cholody T, Michejda CJ, Waters SJ, Herman TS, Woynarowski JM, and Woynarowska BA: Caspase-mediated apoptosis and caspase-independent cell death induced by irofulven in prostate cancer cells. Mol Cancer Ther 2004;3:1385-1389.
11. Garland JM, and Rudin C: Cytochrome c induces caspase-dependent apoptosis in intact hematopoietic cells and overrides apoptosis suppression mediated by bcl-2, growth factor signaling, MAP-kinase-kinase, and malignant change. Blood 1998;92:1235-1246.
12. Enneking WF: A system of staging musculoskeletal neoplasms. Clin Orthop 1986;204:9-24.
13. Jackel MC, Dorudian MA, Marx D, Brinck U, Schauer A, and Steiner W: Spontaneous apoptosis in laryngeal squamous-cell carcinoma is independent of bcl-2 and bax protein expression. Cancer 1999;85:591-599.
14. Bieling P, Rehan N, Winkler P, Helmke K, Maas R, Fuchs N, Bielack S, Heise U, Jurgens H, Treuner J, Romanowski R, Exner U, Kotz R, and Winkler K: Tumor size and prognosis in aggressively treated osteosarcoma. J Clin Oncol 1996;14:848-858.
15. Carsi B, and Rock MG: Primary osteosarcoma in adults older than 40 years. Clin Orthop 2002;397:53-61.
16. Copeland MM, and Sutow WW: Osteogenic sarcoma: the past, present, and future. Int Adv Surg Oncol 1979;2:177-200.
17. Basu A, and Haldar S: The relationship between Bcl-2, Bax and p53: consequences for cell cycle progression and cell death. Mol Hum Reprod 1998;4:1099-1109.
18. Krajewska M, Krajewski S, Epstein JI, Shabaik A, Sauvageot J, Song K, Kitada S, and Reed JC: Immunohistochemical analysis of bcl-2, bax, bcl-x, and mcl-1 expression in prostate cancers. Am J Pathol 1996;148:1567-1576.
19. Charalambous GK, Gomatos IP, Konstadoulakis MM, Messaris EG, Manouras AJ, Apostolou AE, Leandros EA, Karayannis MK, and Androulakis GA: Protein expression of bax, bcl-2, and p53 in patients with non-Hodgkin's gastric lymphoma: prognostic significance. World J Surg 2000;24:608-614.
20. Groeger AM, Esposito V, De Luca A, Cassandro R, Tonini G, Ambrogi V, Baldi F, Goldfarb R, Mineo TC, Baldi A, and Wolner E: Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-xL in resected non-small-cell lung cancers. Histopathology 2004;44:54-63.
21. Takita J, Yang HW, Bessho F, Hanada R, Yamamoto K, Kidd V, Teitz T, Wei T, and Hayashi Y: Absent or reduced expression of the caspase-8 gene occurs frequently in neuroblastoma, but not commonly in Ewing sarcoma or rhabdomyosarcoma. Med Pediatr Oncol 2000;35:541-543.
22. Pingoud-Meier C, Lang D, Janss AJ, Rorke LB, Phillips PC, Shalaby T, and Grotzer MA: Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma. Clin Cancer Res 2003;9:6401-6409.
23. Oltvai ZN, Milliman CL, and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-619.
24. Otter I, Conus S, Ravn U, Rager M, Olivier R, Monney L, Fabbro D, and Borner C: The binding properties and biological activities of Bcl-2 and Bax in cells exposed to apoptotic stimuli. J Biol Chem 1998;273:6110-6120.
25. Yin C, Knudson CM, Korsmeyer SJ, and Van Dyke T: Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 1997;385:637-640.
26. Kawauchi S, Fukuda T, Oda Y, Saito T, Oga A, Takeshita M, Yokoyama K, Chuman H, Iwamoto Y, Sasaki K, and Tsuneyoshi M: Prognostic significance of apoptosis in synovial sarcoma: correlation with clinicopathologic parameters, cell proliferative activity, and expression of apoptosis-related proteins. Mod Pathol 2000;13:755-765.
27. Pagnano KB, Silva MD, Vassallo J, Aranha FJ, and Saad ST: Apoptosis-regulating proteins and prognosis in diffuse large B cell non-Hodgkin's lymphomas. Acta Haematol 2002;107:29-34.
28. Skirnisdottir I, Seidal T, Gerdin E, and Sorbe B: The prognostic importance of p53, bcl-2, and bax in early stage epithelial ovarian carcinoma treated with adjuvant chemotherapy. Int J Gynecol Cancer 2002;12:265-276.
29. Georgiou A, Gomatos IP, Ferekidis E, Syrigos K, Bistola V, Giotakis J, Adamopoulos G, and Androulakis G: Prognostic significance of p53, bax and bcl-2 gene expression in patients with laryngeal carcinoma. Eur J Surg Oncol 2001;27:574-558.
30. Chandra D, Liu JW, and Tang DG: Early mitochondrial activation and cytochrome c up-regulation during apoptosis. J Biol Chem 2002;277:50842-50854.
31. Nicholson DW: Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 1999;6:1028-1042.
32. Kumar S: Mechanisms mediating caspase activation in cell death. Cell Death Differ 1999;6:1060-1066.
33. Virkajarvi N, Paakko P, and Soini Y: Apoptotic index and apoptosis influencing proteins bcl-2, mcl-1, bax and caspases 3, 6 and 8 in pancreatic carcinoma. Histopathology 1998;33:432-439.
34. Yoo NJ, Kim HS, Kim SY, Park WS, Kim SH, Lee JY, and Lee SH: Stomach cancer highly expresses both initiator and effector caspases: an immunohistochemical study. APMIS 2002;110:825-832.
35. Soini Y, and Paakko P: Apoptosis and expression of caspases 3, 6 and 8 in malignant non-Hodgkin's lymphomas. APMIS 1999;107:1043-1050.
36. Joseph B, Ekedahl J, Sirzen F, Lewensohn R, and Zhivotovsky B: Differences in expression of procaspases in small cell and non-small cell lung carcinoma. Biochem Biophys Res Commun 1999;262:381-387.
37. Ogawa Y, Takahashi T, Kobayashi T, Kariya S, Nishioka A, Hamasato S, Moriki T, Seguchi H, Yoshida S, and Sonobe H: Immunocytochemical characteristics of human osteosarcoma cell line HS-Os-1: possible implication in apoptotic resistance against irradiation. Int J Mol Med 2004;14:397-403.
38. Zuzak TJ, Steinhoff DF, Sutton LN, Phillips PC, Eggert A, and Grotzer MA: Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/medulloblastoma. Eur J Cancer 2002;38:17.
39. Bodey B, Bodey V, Siegel SE, Nasir A, Coppola D, Hakam A, and Kaiser HE: Immunocytochemical detection of members of the caspase cascade of apoptosis in high-grade astrocytomas. In Vivo 2004;18:593-602.
40. Palmerini F, Devilard E, Jarry A, Birg F, and Xerri L: Caspase 7 downregulation as an immunohistochemical marker of colonic carcinoma. Hum Pathol 2001;32:461-467.
41. Winter RN, Kramer A, Borkowski A, and Kyprianou N: Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res 2001;61:1227-1232.
42. Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm FG, Look AT, Lahti JM, and Kidd VJ: Caspase-8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 2000;6:529-535.